Yomeishu Seizo
2540.TTSE PRIME
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| ― | 70.07% |
| ― | 70.07% |
| ― | 70.07% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 7
| Nomura Asset Management Co., Ltd. | 1.22% |
| - | 0.54% |
| - | 0.26% |
| NOMURA INTERNATIONAL PLC | 0.25% |
| Nomura Securities Co., Ltd. | 0.08% |
| - | 0.02% |
| Taisho Pharmaceutical Holdings Co., Ltd. | 0.00% |
Ownership history · 19
| Holder | Ratio | Change |
|---|---|---|
| Nomura Securities Co., Ltd.2026-04-21 | 0.08% | -0.03pp |
| NOMURA INTERNATIONAL PLC2026-04-21 | 0.25% | -4.74pp |
| Nomura Asset Management Co., Ltd.2026-04-21 | 1.22% | +0.13pp |
| -2026-04-20 · amended | 0.02% | new |
| -2026-04-20 · amended | 0.26% | new |
| -2026-04-20 · amended | 0.54% | new |
| Nomura Securities Co., Ltd.2026-03-19 · amended | 0.11% | new |
| Nomura Asset Management Co., Ltd.2026-03-19 · amended | 1.09% | new |
| NOMURA INTERNATIONAL PLC2026-03-19 · amended | 4.99% | new |
| ―2025-03-28 · amended | 0.00% | -0.02pp |
| ―2025-03-28 · amended | 28.13% | no change |
| ―2025-03-28 · amended | 41.94% | new |
| ―2025-03-28 · amended | 0.02% | no change |
| ―2025-03-28 · amended | 28.13% | +0.14pp |
| ―2025-03-28 · amended | 0.02% | new |
| ―2025-03-28 · amended | 27.99% | new |
| Taisho Pharmaceutical Holdings Co., Ltd.2025-03-28 · amended | 0.00% | -20.00pp |
| Taisho Pharmaceutical Holdings Co., Ltd.2024-11-07 | 20.00% | +20.00pp |
| Taisho Pharmaceutical Holdings Co., Ltd.2024-11-07 | 0.00% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.